ICP-723

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ICP-723, covering 2025-09-02 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors [Phase 1, Phase 2]

See pricing